Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
drugs
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
akcea therapeutics
alnylam pharmaceuticals
antibiotics
arvinas
astrazeneca
biotech
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
clinical trials
detroit
detroit blog main
detroit top stories
entasis therapeutics
european medicines agency
gritstone oncology
guardant health
harvard pilgrim health care
hereditary transthyretin amyloidosis
indiana
indiana blog main
indiana top stories
inotersen
institute for clinical and economic review
ipo
kodiak sciences
What
make
2
×
way
2
×
alnylam
approves
biotechs
cells
chose
close
company
device
drug
ema
employ
europe
fda
firms
follows
gene
harmful
hits
interference
ipo
ipos
life
medical
medicine
method
mute
open
protein
q
quarter
rna
rnai
science
uses
week
window
Language
Current search:
make
×
way
×
boston
×
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
